Fig. 6.
Anti-PCSK9 mAb1 and anti-LDLR mAbB do not affect expression of other cell receptors. Protein lysates from HepG2 cells treated with PCSK9 with or without mAb1 (A) or mAbB (B) were separated by SDS-PAGE and analyzed by Western blots probed with antibodies to LDLR, VLDLR, SR-B1, LRP1, CD36, or β-actin.